Huakang Biomedical Holdings Company Limited (8622.HK) HKSE

0.52

+0.03(+6.12%)

Updated at November 07 03:59PM

Currency In HKD

Valuation

Market Cap67.97M
Enterprise Value40.56M
P/E Ratio-50.2
PEG Ratio9.14
Price/Sales Ratio9.25
Price/Book Ratio4.58
Enterprise/Revenue8.07
Enterprise/EBITDA-57.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.2

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.09

Income Statement

Revenue25.36M
Revenue/Share0.05
Gross Profit17.07M
EBITDA-3.41M
Net Income-4.16M
Diluted EPS-0.01

Balance Sheet

Total Cash36.73M
Total Cash/Share0.07
Total Debt6.42M
Total Debt/Equity0.12
Current Ratio4
Book Value Per Share0.1

Price History

52-Week Change153.66
52-Week High0.75
52-Week Low0.12
Moving Average 50 Days0.44
Moving Average 200 Days0.38

Statistics

Average Volume1.66M
Shares Outstanding500.47M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A